Introduction Biomarkers have been investigated in order to speed up diagnosis of VAP, a common condition in ICU patients. TREM-1 is a protein involved in amplification of immune responses to bacterial and fungal infection and exists as soluble and surface forms.1 2 The diagnostic value of soluble TREM-1 in broncho-alveolar lavage fluid (BALF) in VAP is controversial.3 Therefore the utility of surface TREM-1 for diagnosing VAP in a two-compartment model (BALF and blood) was investigated.
Methodology Paired blood and BALF were obtained in consenting patients in the following groups: (1) Ventilated patients with VAP diagnosed on semi-quantitative microbiology and Clinical Pulmonary Infection Score (CPIS); (2) Ventilated patients without sepsis; (3) Day-case bronchoscopy patients without evidence of infection. Flow cytometry was performed on cell pellets derived from simultaneous BALF and blood samples. Surface TREM-1, CD11b (immune cell activation marker) and L-selectin (immune cell migration marker) levels were measured on monocytes and neutrophils. At the same time an inflammatory cytokine panel (comprising IL-1β, IL-6, IL-8 and soluble TREM-1) was measured by ELISA in the paired blood and BALF samples.
Results Expression of TREM-1 and CD11b on monocytes were significantly elevated in BALF samples obtained from the VAP patient group. There was no change in blood surface TREM-1 and CD11b levels between the different patient groups. The BALF/blood ratio of monocytic TREM-1 increased the discrimination between the VAP and non-VAP groups (Abstract S77 Figure 1). Soluble TREM-1 levels were not significantly different between the groups. There was no difference in peripheral blood white cell count, CRP, expression of CD11b, L-selectin and inflammatory cytokines between VAP and disease controls.
Conclusion The BALF/blood ratio of monocytic surface TREM-1 discriminates between the VAP and non-VAP groups. Measurement of surface TREM-1 using a two-compartment index may have utility in diagnosing VAP.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.